Numinus Wellness, Inc. (NUMIF)
0.0278
-0.01
(-17.75%)
USD |
OTCM |
Sep 08, 16:00
Numinus Wellness Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 29, 2024 | 20.11 |
| November 27, 2024 | 19.72 |
| November 26, 2024 | 18.44 |
| November 25, 2024 | 20.67 |
| November 22, 2024 | 17.93 |
| November 21, 2024 | 18.44 |
| November 20, 2024 | 16.37 |
| November 19, 2024 | 15.76 |
| November 18, 2024 | 17.04 |
| November 15, 2024 | 22.35 |
| November 14, 2024 | 29.83 |
| November 13, 2024 | 41.62 |
| November 12, 2024 | 33.52 |
| November 11, 2024 | 27.93 |
| November 08, 2024 | 20.98 |
| November 07, 2024 | 13.27 |
| November 06, 2024 | 11.17 |
| November 05, 2024 | 11.68 |
| November 04, 2024 | 11.45 |
| November 01, 2024 | 12.54 |
| October 31, 2024 | 11.23 |
| October 30, 2024 | 10.95 |
| October 29, 2024 | 12.63 |
| October 28, 2024 | 11.73 |
| October 25, 2024 | 11.17 |
| Date | Value |
|---|---|
| October 24, 2024 | 12.04 |
| October 23, 2024 | 11.45 |
| October 22, 2024 | 11.17 |
| October 21, 2024 | 10.67 |
| October 18, 2024 | 11.96 |
| October 17, 2024 | 12.57 |
| October 16, 2024 | 12.23 |
| October 15, 2024 | 11.17 |
| October 14, 2024 | 12.01 |
| October 11, 2024 | 12.28 |
| October 10, 2024 | 12.40 |
| October 09, 2024 | 12.69 |
| October 08, 2024 | 13.16 |
| October 07, 2024 | 12.85 |
| October 04, 2024 | 13.40 |
| October 03, 2024 | 13.41 |
| October 02, 2024 | 13.21 |
| October 01, 2024 | 13.08 |
| September 30, 2024 | 13.18 |
| September 27, 2024 | 12.35 |
| September 26, 2024 | 12.87 |
| September 25, 2024 | 12.83 |
| September 24, 2024 | 13.18 |
| September 23, 2024 | 13.16 |
| September 20, 2024 | 12.29 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 16.25 |
| Edesa Biotech, Inc. | 116.85 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 1.746 |
| PS Ratio | 1.683 |
| Price to Free Cash Flow | 9.451 |
| Price | 0.0278 |
| Earnings Yield | 57.28% |
| Market Cap | 8.898M |
| Normalized PE Ratio | 1.652 |